InvestorsHub Logo
Followers 1
Posts 182
Boards Moderated 0
Alias Born 01/27/2006

Re: wjlknew post# 5100

Monday, 05/21/2007 11:25:03 AM

Monday, May 21, 2007 11:25:03 AM

Post# of 6490
The glass is half-empty or half-full. Why wouldn't CEPH? It's all down to money and patents. CEPH has the ALS patents (at least in Europe). There will be quite an interesting mix of interests if ALS would pan out. INSM has just to wait it out. Does DNA want to partner then half of proceeds go to INSM + recovery of half of development costs.

Again: if the absolute amount of money to be made is large enough which partner doesn't really matter.

E.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News